Daniel Malone
Rheumatology · Beaver Dam, WINPI 1346216371
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $384,040 of the $504,582 with a category attached, or 76.1%. 20 manufacturers reported payments, led by AbbVie at 57.2% of the total. Reporting peaked in 2019 at $131,237 and has fallen 55.3% since, to $58,715 in 2025. Among rheumatology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 840 payments — averaging $600.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$288K
- AstraZeneca$178K
- Mallinckrodt Hospital Products Inc.$12K
- Mallinckrodt Enterprises LLC$8K
- Pfizer$8K
- Fujifilm Sonosite, Inc.$5K
- plus $4K from 14 others
What the payments were for
- Consulting fees$3,9501%
- Speaking & faculty fees$384,04076%
- Travel & lodging$98,36419%
- Food & beverage$17,8494%
- Education$3790%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 454 | $288,439 |
| AstraZeneca(2 entities) | 269 | $178,304 |
| Mallinckrodt Hospital Products Inc. | 21 | $12,440 |
| Mallinckrodt Enterprises LLC | 10 | $8,238 |
| Pfizer | 18 | $8,118 |
| Fujifilm Sonosite, Inc. | 8 | $5,166 |
| Novartis | 15 | $999 |
| Lilly USA, LLC | 10 | $506 |
| Amgen | 5 | $412 |
| GSK | 6 | $387 |
| Radius Health, Inc. | 4 | $312 |
| UCB, Inc. | 4 | $298 |
| Kyowa Kirin, Inc. | 3 | $282 |
| Sobi, Inc | 3 | $221 |
| Janssen Scientific Affairs, LLC | 2 | $190 |
| E.r. Squibb & Sons, L.L.C. | 4 | $145 |
| Boehringer Ingelheim | 1 | $80 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Organon | 1 | $15 |
| Johnson & Johnson | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$190,723
- Strensiq$61,783
- Skyrizi$29,545
- ACTHAR$20,105
- Humira$16,555
- XELJANZ$7,641
- Edge Ultrasound System$3,300
- VEVO MD IMAGING SYSTEM$840
- M-Turbo Ultrasound System$600
- Edge/Edge II Ultrasound System$350
- EVENITY$117
- SIMPONI ARIA$111
- Tymlos$103
- COSENTYX$100
How this compares
$504,582 in reported general payments places this provider in the 95th percentile of 120 rheumatology providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StrensiqAsfotase Alfa | 47 | $6,059,359 |
| ActharCorticotropin | 23 | $1,592,792 |
| RinvoqUpadacitinib | 27 | $178,454 |
| Humira(Cf) PenAdalimumab | 11 | $72,527 |
| Hydroxychloroquine Sulfate | 31 | $1,071 |
| MethotrexateMethotrexate Sodium | 45 | $681 |
| Leflunomide | 15 | $617 |
| Prednisone | 32 | $531 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 13 | $288 |
| Amitriptyline Hcl | 13 | $280 |
| Allopurinol | 19 | $204 |
| Trazodone Hcl | 13 | $104 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaStrensiq | $178,304 | $6,059,35947 claims |
| Mallinckrodt Hospital Products Inc.Acthar | $12,440 | $1,592,79223 claims |
| AbbVieRinvoq | $288,439 | $178,45427 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 120 rheumatology providers in Wisconsin.
Other rheumatology in Beaver Dam
- Kurt OelkeGlendale$750K
- John AlbertGlendale$369K
- Taraneh MehraniMenomonee Falls$176K
- Ekaterina SoforoSheboygan$159K
- Shikha SinglaMilwaukee$108K
- Eric AndersonOconomowoc$103K
- Isabelle AmiguesGreen Bay$80K
- Sara McCoyMadison$80K
- Mark PearsonBrookfield$30K
- Fardina MalikMadison$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.